Tag: Immuno-Oncology

Boehringer Ingelheim launches three phase III trials in precision Oncology

Boehringer Ingelheim has initiated three Phase III clinical trials aimed at advancing…

ME Desk

Harbour BioMed Announces NMPA Acceptance for the Treatment of Advanced Solid Tumors

Harbour BioMed has announced that Chinaโ€™s National Medical Products Administration (NMPA) has…

ME Desk